Clinical Trial Update: Comparison of Heparin Types; Efficacy and Safety [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing different heparin types assessed their efficacy and safety in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: McMaster University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED